• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由血管性血友病因子D3结构域中半胱氨酸残基突变引起的显性1型血管性血友病。

Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor.

作者信息

Eikenboom J C, Matsushita T, Reitsma P H, Tuley E A, Castaman G, Briët E, Sadler J E

机构信息

Department of Hematology, University Hospital, Leiden, The Netherlands.

出版信息

Blood. 1996 Oct 1;88(7):2433-41.

PMID:8839833
Abstract

No defects have been reported in moderately severe type 1 von Willebrand disease (vWD) with a clear autosomal dominant inheritance pattern, and the mechanism underlying this form of vWD remains obscure. We have studied a type 1 vWD family with such a dominant phenotype. The entire coding sequence of the von Willebrand factor (vWF) gene was analyzed by direct sequencing of DNA fragments amplified by polymerase chain reaction. Only one candidate mutation T(3445)-->C in exon 26 was detected that predicts a replacement of cysteine (C) at position 386 of the mature vWF subunit by arginine (R). Both mutant and normal vWF alleles were expressed as shown by analysis of platelet mRNA. This substitution segregates with vWD in the family and was not found in 100 unrelated individuals. The recombinant mutant vWF(C386R) was characterized by expression in 293T cells. The secretion of vWF(C386R) was greatly impaired due to retention in the endoplasmic reticulum. In cotransfections of normal and mutant vWF constructs, the vWF(C386R) subunits caused a dose-dependent decrease in the secretion of vWF. The multimer pattern remained nearly normal and consistent with a dominant vWD type 1 phenotype. The importance of the cysteine residues in the D3 domain of vWF in the pathogenesis of dominant type 1 vWD was further shown by the detection of another cysteine mutation, Cys367-->Phe, in two additional unrelated patients with a similar dominant type 1 vWD phenotype. We conclude that the loss of cysteine pairing in the D3 domain, leaving one free cysteine, can induce a purely quantitative deficiency of vWF by dominantly suppressing the secretion of normal vWF.

摘要

中度严重的1型血管性血友病(vWD)具有明确的常染色体显性遗传模式,尚未有缺陷报道,这种形式的vWD的潜在机制仍不清楚。我们研究了一个具有这种显性表型的1型vWD家族。通过对聚合酶链反应扩增的DNA片段进行直接测序,分析了血管性血友病因子(vWF)基因的整个编码序列。仅检测到一个候选突变,即外显子26中的T(3445)-->C,该突变预测成熟vWF亚基第386位的半胱氨酸(C)被精氨酸(R)取代。通过对血小板mRNA的分析表明,突变型和正常vWF等位基因均有表达。这种替代在家族中与vWD共分离,在100名无关个体中未发现。重组突变体vWF(C386R)通过在293T细胞中表达进行表征。由于在内质网中滞留,vWF(C386R)的分泌受到极大损害。在正常和突变vWF构建体的共转染中,vWF(C386R)亚基导致vWF分泌呈剂量依赖性减少。多聚体模式几乎保持正常,与显性1型vWD表型一致。在另外两名具有相似显性1型vWD表型的无关患者中检测到另一个半胱氨酸突变Cys367-->Phe,进一步证明了vWF D3结构域中的半胱氨酸残基在显性1型vWD发病机制中的重要性。我们得出结论,D3结构域中半胱氨酸配对的丧失,留下一个游离半胱氨酸,可通过显性抑制正常vWF的分泌诱导vWF的单纯定量缺乏。

相似文献

1
Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor.由血管性血友病因子D3结构域中半胱氨酸残基突变引起的显性1型血管性血友病。
Blood. 1996 Oct 1;88(7):2433-41.
2
Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.1型/2E型(2A亚型IIE)血管性血友病、1型维琴察型血管性血友病以及由血管性血友病因子基因的D3、D4、B1 - B3和C1 - C2结构域突变引起的轻型1型血管性血友病的实验室诊断。血管性血友病因子多聚体及血管性血友病因子前肽/抗原比值的作用。
Acta Haematol. 2009;121(2-3):128-38. doi: 10.1159/000214853. Epub 2009 Jun 8.
3
Type 2M:Milwaukee-1 von Willebrand disease: an in-frame deletion in the Cys509-Cys695 loop of the von Willebrand factor A1 domain causes deficient binding of von Willebrand factor to platelets.2M型:密尔沃基-1型血管性血友病:血管性血友病因子A1结构域的Cys509-Cys695环内的框内缺失导致血管性血友病因子与血小板的结合缺陷。
Blood. 1996 Oct 1;88(7):2559-68.
4
Mutations in von Willebrand factor multimerization domains are not a common cause of classical type 1 von Willebrand disease.血管性血友病因子多聚化结构域的突变并非经典1型血管性血友病的常见病因。
Thromb Haemost. 1999 Nov;82(5):1446-50.
5
Laboratory diagnosis and molecular classification of von Willebrand disease.血管性血友病的实验室诊断与分子分类
Acta Haematol. 2009;121(2-3):71-84. doi: 10.1159/000214846. Epub 2009 Jun 8.
6
Molecular genetics of type 2 von Willebrand disease.2型血管性血友病的分子遗传学
Int J Hematol. 2002 Jan;75(1):9-18. doi: 10.1007/BF02981973.
7
Expression and characterization of von Willebrand factor dimerization defects in different types of von Willebrand disease.不同类型血管性血友病中血管性血友病因子二聚化缺陷的表达与特征分析
Blood. 2001 Apr 1;97(7):2059-66. doi: 10.1182/blood.v97.7.2059.
8
Type 1 von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins.1型血管性血友病因子疾病突变Cys1149Arg导致异二聚体的细胞内滞留和降解:寡聚蛋白显性突变的一种可能普遍机制。
Blood. 2001 Nov 15;98(10):2973-9. doi: 10.1182/blood.v98.10.2973.
9
Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.隐性严重1型和3型血管性血友病(VWD)、无症状杂合子携带者与血型O相关的血管性血友病因子缺乏症以及显性1型VWD的特征分析
Clin Appl Thromb Hemost. 2006 Jul;12(3):277-95. doi: 10.1177/1076029606291401.
10
Differential effects of the loss of intrachain- versus interchain-disulfide bonds in the cystine-knot domain of von Willebrand factor on the clinical phenotype of von Willebrand disease.血管性血友病因子胱氨酸结域内链间与链内二硫键缺失对血管性血友病临床表型的不同影响
Thromb Haemost. 2006 Dec;96(6):717-24. doi: 10.1160/th06-08-0460.

引用本文的文献

1
Novel cysteine substitution p.(Cys1084Tyr) causes variable expressivity of qualitative and quantitative VWF defects.新型半胱氨酸取代 p.(Cys1084Tyr) 导致 VWF 质和量缺陷的表现度可变。
Blood Adv. 2022 May 10;6(9):2908-2919. doi: 10.1182/bloodadvances.2021005928.
2
Quantitative 3D microscopy highlights altered von Willebrand factor α-granule storage in patients with von Willebrand disease with distinct pathogenic mechanisms.定量三维显微镜检查突出显示了具有不同致病机制的血管性血友病患者血管性血友病因子α颗粒储存的改变。
Res Pract Thromb Haemost. 2021 Sep 14;5(6):e12595. doi: 10.1002/rth2.12595. eCollection 2021 Aug.
3
Molecular Genetics of von Willebrand Disease in Korean Patients: Novel Variants and Limited Diagnostic Utility of Multiplex Ligation-Dependent Probe Amplification Analyses.
韩国患者血管性血友病的分子遗传学:新型变异及多重连接依赖性探针扩增分析的有限诊断效用。
Ann Lab Med. 2019 Nov;39(6):545-551. doi: 10.3343/alm.2019.39.6.545.
4
Diagnostic approach to von Willebrand disease.血管性血友病的诊断方法。
Blood. 2015 Mar 26;125(13):2029-37. doi: 10.1182/blood-2014-08-528398. Epub 2015 Feb 23.
5
The molecular genetics of von Willebrand disease.血管性血友病的分子遗传学
Turk J Haematol. 2012 Dec;29(4):313-24. doi: 10.5505/tjh.2012.39205. Epub 2012 Dec 5.
6
Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storage.2A 型血管性血友病通过 VWF 多聚体化、分泌、ADAMTS-13 易感性和调控储存缺陷的机制交汇。
Blood. 2012 May 10;119(19):4543-53. doi: 10.1182/blood-2011-06-360875. Epub 2012 Mar 19.
7
Biogenesis of Weibel-Palade bodies in von Willebrand's disease variants with impaired von Willebrand factor intrachain or interchain disulfide bond formation.血管性血友病变异体中 Weibel-Palade 体的生物发生,这些变异体中存在 von Willebrand 因子链内或链间二硫键形成障碍。
Haematologica. 2012 Jun;97(6):859-66. doi: 10.3324/haematol.2011.057216. Epub 2011 Dec 29.
8
Von Willebrand disease: an overview.血管性血友病:概述
Indian J Pharm Sci. 2011 Jan;73(1):7-16. doi: 10.4103/0250-474X.89751.
9
Intracellular storage and regulated secretion of von Willebrand factor in quantitative von Willebrand disease.定量 von Willebrand 病中血管性血友病因子的细胞内储存和调节分泌。
J Biol Chem. 2011 Jul 8;286(27):24180-8. doi: 10.1074/jbc.M110.215194. Epub 2011 May 19.
10
The mutation N528S in the von Willebrand factor (VWF) propeptide causes defective multimerization and storage of VWF.血管性血友病因子(VWF)前肽中的 N528S 突变导致 VWF 多聚体化和储存缺陷。
Blood. 2010 Jun 3;115(22):4580-7. doi: 10.1182/blood-2009-09-244327. Epub 2010 Mar 24.